Published on | 1 year ago
Programmes Digital, Industry & Space Horizon EuropeSPACE4Cities is a Horizon Europe funded pre-commercial procurement project that aims to procure replicable solutions, via smart use of European satellite data, for better and more dynamic management of public space, green areas, transport infrastructure and city maintenance—and the cities’ overall resilience.
To prepare the €2.87 million Call for Tenders and its specifications, SPACE4Cities partners are conducting an Open Market Consultation (OMC) from June 2024 until the end of October 2024.
In the SPACE4Cities Pre-Commercial Procurement, five innovative solutions will be selected at the end of a three-step process and will then be implemented for five public procurers: Helsinki, Amsterdam, Athens (Attica region), Ghent and Guimarães.
To this end, Suppliers will be invited to submit their tenders in Q1 2025 while the Call for tenders is open. Suppliers may be either companies, research centres or non-profit organisations and may submit a tender as part of a consortium or as a single entity.
To prepare the €2.87 million Call for Tenders and its specifications, SPACE4Cities partners are conducting an Open Market Consultation (OMC) from June 2024 until the end of October 2024. The questions asked, feedback and results obtained during the OMC will help SPACE4Cities partners to elaborate the most appropriate requirements possible.
Participating in the OMC is an undeniable asset in order to prepare for the call for tenders. In fact, suppliers are invited to explain what is currently being done on the market, how they can innovate, comment on the feasibility of the PCP process, and start thinking about their submission.
To allow that, SPACE4Cities strives to create an open forum via the following tools:
SPACE4Cities commits to keep a strictly fair, transparent and open market consultation and reminds all stakeholders that participating in the OMC does not provide any preference for the forthcoming €2.87 million call for tenders, planned in the first quarter of 2025. However, all insights received until November 2024 will help to refine our challenges and feed our specifications.
Participation in the OMC is not mandatory in order to participate in the Call for Tenders.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.